Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression

Authors

Jörn C. Albring, Washington University School of Medicine in St. Louis
Michelle M. Sandau, Washington University School of Medicine in St. Louis
Aaron S. Rapaport, Washington University School of Medicine in St. Louis
Brian T. Edelson, Washington University School of Medicine in St. Louis
Ansuman Satpathy, Washington University School of Medicine in St. Louis
Mona Mashayekhi, Washington University School of Medicine in St. Louis
Stephanie K. Lathrop, Washington University School of Medicine in St. Louis
Chyi-Song Hsieh, Washington University School of Medicine in St. LouisFollow
Matthias Stelljes, University of Muenster
Marco Colonna, Washington University School of Medicine in St. LouisFollow
Theresa L. Murphy, Washington University School of Medicine in St. Louis
Kenneth M. Murphy, Washington University School of Medicine in St. Louis

Journal

Journal of Experimental Medicine

Publication Date

2010

Volume

207

Issue

12

Inclusive Pages

2551-2559

Document Type

Open Access Publication

DOI

10.1084/jem.20102017

Rights and Permissions

Albring, Jörn, et al. Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. J Exp Med 2010 207:2551-2559. Published November 15, 2010, doi:10.1084/jem.20102017

Recommended Citation

Albring, Jörn C.; Sandau, Michelle M.; Rapaport, Aaron S.; Edelson, Brian T.; Satpathy, Ansuman; Mashayekhi, Mona; Lathrop, Stephanie K.; Hsieh, Chyi-Song; Stelljes, Matthias; Colonna, Marco; Murphy, Theresa L.; and Murphy, Kenneth M., "Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression." Journal of Experimental Medicine. 207, 12. 2551-2559. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/478